Literature DB >> 583138

Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy.

G Hauptmann, F Petitjean, J M Lang, F Oberling.   

Abstract

A patient with an extensive lymphosarcoma of the spleen without involvement of other lymphoid organs and hypogammaglobulinaemia showed the characteristic complement profile of an acquired C1-inhibitor deficiency. Both functional and immunochemical studies revealed extremely low levels of the inhibitor of C1-esterase. Correction of the low levels of early acting complement components and of the low C1-inhibitor level followed the splenectomy. In vitro tests showed that lymphosarcoma tissue pieces or cells were able to interact with complement, resulting in a depletion of the haemolytic activity. These findings provide evidence that tumour cells were responsible for the abnormalities of the complement system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583138      PMCID: PMC1537769     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Classical pathway complement activation in association with paraproteinaemia.

Authors:  P F Naish; C Collins; J Barratt
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

2.  Treatment of acquired C1-inhibitor deficiency with danazol.

Authors:  G Hauptmann; S Mayer; J M Lang; F Oberling; G Mayer
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

3.  A simple one-step hemolytic assay for C2 with C2-deficient human serum.

Authors:  B Y Ngan; E W Gelfand; J O Minta
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

4.  Angio-oedema--? acquired C1 esterase inhibitor deficiency.

Authors:  M J Cheesbrough
Journal:  Br J Dermatol       Date:  1978-07       Impact factor: 9.302

5.  Acquired C1 esterase deficiency with cold agglutinin disease associated with monoclonal IgM antibodies.

Authors:  T B Wallington
Journal:  Br J Dermatol       Date:  1978-07       Impact factor: 9.302

6.  Danazol and C1 esterase inhibitor deficiency.

Authors:  S H Cohen; S M Koethe
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

7.  The presence of active C1 (C-1) on peripheral human lymphocytes.

Authors:  H Kitamura; H Teshima; N K Day
Journal:  Vox Sang       Date:  1978       Impact factor: 2.144

8.  Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality.

Authors:  A D Schreiber; B Zweiman; P Atkins; F Goldwein; G Pietra; B Atkinson; N I Abdou
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

9.  Acquired C1-inhibitor deficiency in essential cryoglobulinemia and macrocryoglobulinemia.

Authors:  P Casali; P Borzini; P Pioltelli; F Invernizzi; C Zanussi
Journal:  Acta Haematol       Date:  1978       Impact factor: 2.195

10.  Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL).

Authors:  N K Day; J B Winfield; T Gee; R Winchester; H Teshima; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

View more
  4 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

2.  Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement.

Authors:  J A Schifferli; M Pascual; G Steiger; M Schapira; J E Ryser; J Estreicher; A Dash
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

3.  Acquired C1-inhibitor deficiency: 7 patients treated with rituximab.

Authors:  Albanne Branellec; Laurence Bouillet; Nicolas Javaud; Arsène Mekinian; Isabelle Boccon-Gibod; Claire Blanchard-Delaunay; Eric Oksenhendler; Yann Ollivier; Bertrand Dunogué; Stephanie Amarger; Denise Ponard; Christian Drouet; Luc Mouthon; Michel Thomas; Olivier Fain
Journal:  J Clin Immunol       Date:  2012-04-20       Impact factor: 8.317

4.  Acquired angioedema.

Authors:  Marco Cicardi; Andrea Zanichelli
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.